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Mini-abstract: 
The study aimed to prospectively evaluate if serum calcium is related to diabetes incidence 
in Hong Kong Chinese. The results showed that serum calcium has a significant association 
with increased risk of diabetes. The result of meta-analysis reinforced our findings. 
Abstract 
Purpose This study aimed to evaluate the association of serum calcium, including serum 
total calcium and albumin-corrected calcium, with incident diabetes in Hong Kong Chinese.  
Methods We conducted a retrospective cohort study in 6096 participants aged 20 or above 
and free of diabetes at baseline. Serum calcium was measured at baseline. Incident diabetes 
was determined from several electronic databases. We also searched relevant databases for 
studies on serum calcium and incident diabetes and conducted a meta-analysis using fixed-
effect modelling. 
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Results During 59130.9 person-years of follow-up, 631 participants developed diabetes. 
Serum total calcium and albumin-corrected calcium were associated with incident diabetes 
in the unadjusted model. After adjusting for demographic and clinical variables, the 
association remained significant only for serum total calcium (HR 1.32, 95%CI 1.02-1.70, 
highest vs. lowest quartile).  In a meta-analysis of four studies including the current study, 
both serum total calcium (pooled RR 1.38; 95%CI 1.15-1.65; I2=5%, comparing extreme 
quantiles) and albumin-corrected calcium (pooled RR 1.29; 95%CI 1.03-1.61; I2=0%, 
comparing extreme quantiles) were associated with incident diabetes. Penalized regression 
splines showed that the association of incident diabetes with serum total calcium and 
albumin-correlated calcium was non-linear and linear, respectively. 
Conclusions Elevated serum calcium concentration is associated with incident diabetes. 
The mechanism underlying this association warrants further investigation.  
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Introduction 
Calcium is a vital component in bone metabolism and is essential for other important 
biological functions including nerve impulse transmission, blood clotting, cell signaling, 
and muscle contraction [1]. Calcium homeostasis is tightly controlled by calcitonin, 
parathyroid hormone (PTH), and calcitriol [1]. Elevated serum calcium concentration has 
been demonstrated to be associated with a wide range of health outcomes including 
cardiovascular morbidity and mortality [2,3], and metabolic syndrome [4]. 
 
Growing evidence suggests that calcium homeostasis may be linked to glucose metabolism 
and development of diabetes. Calcium-sensing receptor (CaR) is expressed not only in 
tissues involved in calcium homeostasis (e.g. parathyroid gland), but also in other tissues, 
such as pancreatic islets of Langerhans [5]. An in vitro study showed that activation of CaR 
in pancreatic beta-cells initiated an insulin secretory response [6], and is involved in intra-
islet communication between beta-cells [5]. Some [7-9] but not all [10] previous 
observational studies showed that serum calcium concentrations were positively associated 
with impairment of glucose tolerance, insulin resistance and insulin secretion, suggesting 
that more studies are warranted to investigate the association between serum calcium and 
diabetes development. 
 
Recent studies show that serum calcium is associated with an increased risk of diabetes in 
Caucasian populations [10-12]. Since there are ethnic differences in bone and mineral 
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metabolism [13-15], whether serum calcium concentration is also associated with the risk 
of diabetes in Chinese populations remains unknown. In the present study, we aimed to 
evaluate the relationship between serum calcium and the risk of incident diabetes in a 
retrospective Chinese cohort, and to study further the relationship between serum calcium 
and the risk of diabetes in a meta-analysis of observational studies. 
 
Materials and Methods 
Study participants 
The study participants were drawn from the Hong Kong Osteoporosis Study (HKOS), 
which was conducted at the University of Hong Kong Osteoporosis Centre at Queen Mary 
Hospital to determine the genetic and environmental risk factors for osteoporosis and 
related traits. The participants were community-dwelling Southern Chinese men and 
women recruited between 1995 and 2010 during public road shows and health fairs on 
osteoporosis held in various districts of Hong Kong. Details have been described previously 
[16-18]. Baseline demographic data on anthropometric measurements, socioeconomic 
status, education level, and medical and reproductive history were obtained using a 
structured questionnaire administered by a trained research assistant. Additionally, 
information on lifestyle, smoking, alcohol consumption, and physical activity, were also 
recorded. All participants gave informed consent and the study was conducted according to 
the Declaration of Helsinki. The study protocol was approved by the Institutional Review 
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Board of the University of Hong Kong and the Hospital Authority Hong Kong West Cluster 
Hospitals. 
 
To ascertain the clinical outcomes, the osteoporosis database was linked to the electronic 
medical record (EMR) of the Hong Kong Hospital Authority, a publicly funded primary, 
secondary, and tertiary healthcare provider that consists of 37 hospitals and account for 
>90% of the medical care provided in Hong Kong [19]. Among 9,202 participants aged ≥20 
in the study, 1,018 who had diabetes at baseline were excluded for the present study. In 
addition, 173 participants with chronic kidney disease (CKD, defined as eGFR <60 
mL/min/1.73m2) that affects bone and mineral metabolism were also excluded. Participants 
with any missing variable in the multivariable model (n=1,793) or on osteoporosis 
medication (n=122) were also excluded. A total of 6,096 participants were included in the 
final analysis (eligibility flow of study is shown in Supplementary Figure 1). 
 
Ascertainment of diabetes 
Incident diabetes was ascertained from the EMR in several ways: (1) having a diagnosis of 
diabetes (ICD-9 code 250); (2) having a prescription record of diabetic medications; (3) 
having a laboratory record of A1C ≥47.5mmol/mol (≥6.5%) or fasting plasma glucose 
concentration >7.0 mmol/l; (4) having enrolled in a diabetic complication screening 
program. Length of follow-up for each participant was calculated as the time from the 
baseline examination date to the date of first diabetes ascertainment, date of death, or May 
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1, 2014, whichever was earliest. To validate the diabetes ascertainment, we conducted a 
phone interview in 10% of participants (n=610) by a trained research assistant. Kappa 
statistics (prevalence-adjusted and bias-adjusted kappa = 0.881) showed that self-reported 
diabetes and diabetes ascertainment from EMR were in excellent agreement.   
 
Assessment of serum calcium and other covariates 
Serum calcium, phosphate, albumin, and alkaline phosphatase (ALP) were measured with a 
Hitachi 747 random access analyzer (Roche Molecular Biochemicals, Mannheim, 
Germany). Albumin-corrected calcium was calculated using the formula commonly used in 
clinical practice: corrected calcium (mmol/L) = serum total calcium + 0.02*(40 - serum 
albumin (g/L)) [20]. Serum PTH was measured by two-site sandwich chemiluminometric 
assay with a mouse monoclonal anti-human PTH antibody measuring intact PTH (Chiron 
Diagnostic Corporation, East Walpole, Mass., USA) with intraassay and interassay 
coefficients of variation of 5.6 and 6.6%, respectively [18]. Baseline bone mineral density 
(BMD) at the femoral neck was measured using a dual-energy X-ray absorptiometry 
machine (Hologic QDR 4500, Waltham, MA, USA). BMD T-scores were determined 
according to the local Southern Chinese norm. The in vivo precision for hip BMD 
measurement was 1.5%. Although BMD data at other skeletal sites (such as lumbar spine) 
were also available, we studied BMD at the femoral neck because it was more clinically 
relevant for diagnosing osteoporosis and determining fracture risk.  
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Age, sex, smoking status, drinking status, and physical activity were self-reported at 
baseline. Physical activity was defined as having ≥1 hour of exercise per week [16]. Body 
mass index (BMI) was calculated from height (m) and weight (kg) measured during 
baseline examination using a standardized protocol. Since serum vitamin D was not 
measured, season was used as a surrogate to reflect the effect of vitamin D on serum 
calcium. Season was defined as the month in which baseline markers were measured. We 
grouped measurement in summer and autumn (from May to October) as one group and 
measurement in winter and spring (from November to April) as another group [21]. 
 
Meta-analysis  
Systematic search in PubMed, Medline and Cochrane library (2nd July 2015) was 
performed by 2 independent reviewers (K.F.C. and K.C.H.) using search terms ("Serum 
calcium" AND "diabetes", "total serum calcium" AND “diabetes”, "corrected calcium" 
AND diabetes). Potential eligible articles were first identified by screening titles and 
abstracts, and then full articles selected were read and evaluated. Studies were included if 
they reported serum calcium level or albumin-corrected calcium with incident diabetes data, 
the result should include odds ratio (OR) or hazard ratio (HR). We employed the 
Newcastle-Ottawa Scale [22] (9-star based system) to assess the quality of the selected 
studies, the assessment covers the selection of study groups, comparability of study groups, 
outcomes assessment and follow-up. Studies with 9-7, 6-4 and 3-0 score would be 
considered as high, moderate, and low quality respectively. 
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We used risk ratio (RR) as the common measure across studies. HR was considered as 
broadly equivalent to RR. We transformed OR reported in the studies to RR using the 
formula RR = OR/ [(1−P0) + (P0×OR)] where P0 stands for the prevalence of diabetes in US 
in 2014 (9.3%, http://www.diabetes.org/diabetes-basics/statistics/). Heterogeneity across 
studies was assessed; it was considered insignificant if P>0.10 and I2≤50%. The pooled RR 
was calculated using a fixed model with inverse variance. Review Manager 5.3 
(tech.cochrane.org/revman) was the program used for meta-analysis.  
 
Statistical methods 
Baseline participant’s characteristics with and without incident diabetes were compared 
using the Student t test for continuous data and the χ2 test for categorical data. Pearson 
correlation coefficients were calculated to assess the relationship between serum total 
calcium and other variables. Time-to-event analyses were performed and HR and the 95% 
confidence interval (CI) were calculated using Cox proportional hazard models. Survival 
time was calculated from the baseline date to the date of diabetes diagnosis, death, or end of 
study (1 May 2014).  In the Cox-regression model, model 1 was adjusted for age and sex; 
model 2 was further adjusted for BMI, smoking status, drinking status, and physical activity; 
and model 3 was the full adjusted model with further adjustment for serum albumin, 
phosphate, PTH, ALP, femoral neck BMD T-score, and season. For albumin-corrected 
calcium, although serum albumin was used in the calculation of albumin-corrected calcium 
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level, the correlation between these two variables was modest (-0.253, p<0.01, data not 
shown), suggesting that multicollinearity should be minimal. Therefore, we adjusted for 
albumin in model 3. The proportional hazards assumption was evaluated for the variables in 
the final multivariable mortality model using the Schoenfeld residuals method. The 
proportional assumption was not violated in the model. Serum calcium was further modeled 
as quartiles, and the lowest quartile was used as reference. To compare the relative strength 
of association of each variable with incident diabetes, we calculated HRs per 1-SD 
increment from the mean of the continuous variables (standard coefficients). Penalized 
regression spline was used to gain additional insight into the potential nonlinearity of the 
effect of serum calcium using the R packages “pspline” and “survival”. To plot the 
penalized regression spline, outliers of serum calcium were removed using the Median 
Absolute Deviation (MAD) method. The outlier was defined as value smaller than median-
3*MAD or larger than median+3*MAD. In addition, as sensitivity analysis we examined 
the differences of association across predefined subgroups, including sex, age, BMI, 
smoking status, drinking status, and physical activity, using the interaction test. All 
statistical analyses were performed using SPSS version 18.0 software (SPSS Inc, Chicago, 
IL) or R version 3.0.1 (www.R-project.org). 
 
Results 
Baseline characteristics 
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The flow diagram for the study is provided in Supplementary figure 1. For the 6,096 
participants included in our analysis, the mean age at diagnosis of diabetes was 52.5 years 
(range 20 to 96). Baseline characteristics of the 6,096 participants included in the study, 
stratified according to incident diabetes status, are presented in Table 1. Participants with 
incident diabetes were older, with significantly higher BMI, ALP, calcium, and physical 
activity, and significantly lower BMD and PTH concentrations. Serum total calcium was 
positively correlated with BMI, physical activity, serum albumin, serum ALP, serum 
phosphate, and season; whereas it was inversely correlated with BMD and serum PTH. 
 
Serum calcium and incident diabetes 
A total of 631 cases of incident diabetes were observed over a median follow-up of 10.2 
years, with a maximum follow-up of 19.1 years (total follow-up: 59,130.9 person-years; 
10.7 incident diabetes per 1,000 person-years). Serum total calcium and albumin-corrected 
calcium were significantly associated with incident diabetes in the crude model (Table 2). 
After further adjustment for age, sex, lifestyle and other bone and mineral metabolism 
markers (Model 3), the association between diabetes incidence and serum total calcium 
(HR 1.11 per 1-SD increment, 95%CI 1.02-1.21) and albumin-corrected calcium (HR 1.10 
per 1-SD increment, 95%CI 1.02-1.20) remained statistically significant.  
 
When serum total calcium and corrected calcium were analyzed as quartiles, the third and 
highest quartiles of both variables were significantly associated with incident diabetes in 
12 
 
the crude model when comparing with the lowest quartile (Ptrend<0.001, Table 3). After 
further adjustment for age, sex, lifestyle, and other bone and mineral metabolism markers 
(models 1 to 3), the association of serum total calcium with incident diabetes remained 
statistically significant, whereas the association of albumin-corrected calcium became 
insignificant, although the trend across the quartiles was significant (Ptrend = 0.046). In the 
fully adjusted model, participants in the third quartile (HR, 1.37; 95% CI, 1.07 to 1.74) and 
the highest quartile (HR, 1.32; 95% CI, 1.02 to 1.70) of serum total calcium had 
significantly elevated risks for diabetes when compared with participants in the lowest 
quartile. Penalized regression spline for the association of serum calcium and risk of 
diabetes showed that serum total calcium and albumin-correlated calcium had a non-linear 
and linear relationship with incident diabetes, respectively (Supplementary figure 2). The 
associations across the subgroups did not show significant differences (all p for interaction 
>0.05; Supplementary figure 3). 
 
To assess potential bias due to undiagnosed diabetes at baseline, we performed a sensitivity 
analyses for serum total calcium, which excluded participants with incident diabetes in the 
first 3-years or the first 5-years of follow up. Slightly increased HRs were observed with 
significant trend across quartiles (Ptrend = 0.039 when we exclude cases in the first 3-years; 
Ptrend =0.031, when we exclude cases in the first 5-years; Supplementary Table 1). 
 
Meta-analyses of observational studies on serum calcium and incident diabetes 
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We performed a meta-analysis of observational studies to summarize the existing evidence 
of the association between serum total calcium and albumin-corrected calcium with the risk 
of diabetes. The screening process is shown in Supplementary Figure 4. Three studies [10-
12] together with our current study were selected. Additional data were obtained from the 
authors of the two studies [10,12]. The characteristics of the studies are summarized in 
Supplementary Table 2. The risk estimates comparing extreme quantiles, except the Insulin 
Resistance Atherosclerosis Study (IRAS) which used the second quintile as a reference 
group, were pooled for analysis.  Figure 1a) shows a forest plot of the association between 
serum total calcium level and diabetes risk, whereas Figure 1b) shows the association 
between corrected calcium and diabetes risk. No statistically significant heterogeneity was 
found across studies (serum total calcium, Pheterogeneity = 0.35, I
2 = 5%; albumin-corrected 
calcium, Pheterogeneity = 0.45, I
2 = 0%). The fixed effect model suggested an increased risk of 
diabetes in individuals with elevated serum total calcium level (pooled RR, 1.38; 95% CI: 
1.15 to 1.65; Pmeta = 0.001) and albumin-corrected calcium level (pooled RR, 1.29; 95% CI: 
1.03 to 1.61; Pmeta = 0.02). Similar results were observed even in random effects model 
(data not shown). 
 
Discussion 
In this study we observed that serum total calcium was associated with incident diabetes, 
and this finding was further confirmed in the meta-analysis. The association was 
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independent of several established risk factors of diabetes, suggesting that serum calcium is 
independently related to the risk of diabetes. 
 
Our study showed a positive, non-linear association between serum total calcium and 
incident diabetes. Participants with a total calcium >2.44 mmol/l had a 32% increased risk 
of diabetes compared to the reference group. The findings are consistent with the results of 
two studies included in the meta-analysis. In the Tromso Study [11], participants with the 
highest category of serum total calcium (2.50-2.60 mmol/L) had significant increased risk 
of incident diabetes (HR 1.36, 95% CI 1.04-1.77) when compared to those in the lowest 
category (2.20-2.29 mmol/L). The IRAS study reported a non-linear association between 
calcium and incident diabetes [10]. Our result, by pooling the data from Tromso and IRAS 
studies together with our current study in a meta-analysis, provided further evidence to 
support the association. 
 
Unlike serum total calcium, we observed a positive linear association between albumin-
corrected calcium and diabetes risk, which is consistent with the finding reported in the 
IRAS study [10]. However, when albumin-correlated calcium was analyzed in quartiles in 
the HKOS, the association was non-significant. This finding is in agreement with the 
Prevención con Dieta Mediterránea (PREDIMED) study [11] and the IRAS study [10]. The 
insignificant association in each individual study could be due to the small sample size in 
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each study, resulting in insufficient power to detect the association. Nevertheless, our meta-
analysis showed that serum calcium is associated with incident diabetes. 
 
The role of serum calcium in diabetes development is unclear but emerging evidence 
indicated that calcium may affect glucose metabolism. Calcium ions are involved in the 
regulation of insulin secretion and action at cellular level [23], potentially through the 
activation of CaR [5,6]. Recent studies showed a potential interaction between calcium and 
adiponectin. Adiponectin has three calcium-binding sites and the formation of trimeric 
adiponectin can be triggered by calcium [24]. Interestingly, a significant interaction 
between total serum calcium and adiponectin levels on all-cause mortality in end-stage 
renal disease (ESRD) people has been reported. Adiponectin was significantly associated 
with all-cause mortality in ESRD people with high serum total calcium (defined as >2.33 
mmol/l) levels only [25], which is equivalent to the second to fourth quartile in the current 
study. Given that patients with ESRD are different from the general population, further 
studies investigating the associations between serum calcium in the general population with 
metabolic risk factors are warranted.  
 
In the IRAS study, a significant association between serum phosphate concentrations and 
risk of diabetes was reported. However, we did not found any significant association 
between these two variables in the current study even when using the same cutoff 
(Supplementary Table 3). Difference in findings could be due to ethnic differences in 
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phosphate metabolism [26]. A study by Yan et al. showed that Chinese subjects had a more 
rapid renal clearance of phosphate compared to the British and Gambian, resulting in little 
change in the phosphate level after oral phosphate administration [27]. With a stable 
phosphate level, the effect of phosphate on the development of diabetes may be minimal.  
 
PTH and vitamin D regulate calcium homeostasis and are important bone markers. 
Therefore, the effects of PTH and vitamin D on the association of serum calcium with 
incident diabetes are worth investigating. The current study showed no significant 
association between serum PTH and incident diabetes in any models (data not shown), 
suggesting that serum PTH has no effect on incident diabetes, and the effect of calcium on 
incident diabetes is independent of PTH regulation. A previous study showed that the 
association between PTH and glycemic traits was confounded by serum calcium levels [7], 
further highlighting the role of serum calcium in glycemic traits. Unfortunately, vitamin D 
levels were not available in the current study. Several observational studies, including a 
meta-analysis, reported that low peripheral levels of vitamin D appeared to be associated 
with an increased risk of diabetes [28-30]. However, randomized clinical trials did not 
report consistent findings. In the Women’s Health Initiative trial, no reduction in the risk of 
diabetes was found in 2,291 postmenopausal women treated with 400 IU/day of vitamin D3 
supplement plus 1,000mg/day of calcium. The absence of association may be explained by 
the low dose of vitamin D3 and suboptimal supplement adherence (<60%) [31]. Results 
from other trials were not conclusive due to small sample size, large heterogeneity in study 
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design, and different techniques to measure vitamin D concentrations. Therefore, a large 
trial with well-defined assessment is warranted to investigate the association between 
vitamin D, calcium and diabetes. 
 
Our study has several strengths. The study population is large. The long follow-up and 
large number of incident cases of diabetes provided ample statistical power. Factors 
affecting bone and mineral metabolism were collected at baseline and were excluded in the 
current study. Sensitivity analysis excluded incident diabetes in the first 3 or 5 years to 
avoid bias. Nevertheless, there are limitations. First, plasma glucose measurements were 
not available on all participants. Glycemic measurements are known to be strong predictors 
of diabetes, and whether the association was confounded by glycemic measurements are 
unknown. However, based on the previous study of serum calcium in incident diabetes [10], 
in which the association between serum calcium and incident diabetes was not confounded 
by fasting and 2-hour glucose concentrations, insulin sensitivity index, or acute insulin 
response, we believe that our findings (on serum calcium at least) are also unlikely to be 
confounded by glycemic measurements. Second, observational data cannot infer causality. 
Third, incident diabetes was ascertained from electronic medical records, which means that 
undiagnosed diabetes could be a limitation. However, the incidence of diabetes in the 
current study (10.7 incident diabetes per 1,000 person-years) is comparable to the figures 
reported in the literature (9.1-9.5 incident diabetes per 1,000 person-years) [32,33], 
suggesting that the problem associated with undiagnosed diabetes should be minimal. 
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Fourth, calcium intake from diet and several important markers of bone and mineral 
metabolism such as vitamin D, parathyroid hormone related protein, and FGF23 were not 
included in the study. Whether the observed associations were confounded by these factors 
remains unknown. Lastly, we do not have the data of blood pressure and lipid profiles, 
which are known risk factors for diabetes. However, in the TROMSO study, there was 
adjustment for these two risk factors and the association remained significant, although the 
HR was slightly decreased.  
 
In conclusion, our study showed that elevated serum calcium concentration, including both 
total calcium and albumin-corrected calcium, was associated with an increased risk of 
diabetes in a Chinese population. Investigation on the role of calcium in the development of 
diabetes is warranted. 
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Table 1. Baseline characteristics of the participants stratified by incident diabetes status. 
Characteristics   
Without incident 
diabetes (n=5,465) 
  
With incident 
diabetes (n=631) 
  P-value 
Correlation 
with serum 
total calcium^ 
Female 
 
3,952  (72.3) 
 
442  (70) 
 
0.23 - 
Age (years) 
 
51.4  ± 16.3 
 
62.1  ± 11.2 
 
<0.001 - 
BMI (kg/m2) 
 
22.5  ± 3.4 
 
25.1  ± 3.8 
 
<0.001 0.034** 
Exercise >1h per week 
 
2,283  (41.8) 
 
331  (52.5) 
 
0.001 0.042** 
Current drinking 
 
455  (8.3) 
 
50  (7.9) 
 
0.729 -0.002 
Current smoking 
 
302  (5.5) 
 
37  (5.9) 
 
0.726 0.004 
Femoral neck BMD T-score 
 
-0.913  ± 1.184 
 
-1.132  ± 1.184 
 
<0.001 -0.025* 
Serum alkaline phosphatase 
(IU/L)   
69.9  ± 23.7 
 
78.4  ± 22.9 
 
<0.001 0.126** 
Serum total calcium (mmol/L)  
 
2.385  ± 0.090 
 
2.400  ± 0.090 
 
<0.001 - 
Serum albumin-corrected 
calcium (mmol/L)   
2.302  ± 0.084 
 
2.321  ± 0.091 
 
<0.001 - 
Serum parathyroid hormone 
(pmol/L)    
3.828  ± 1.613 
 
3.657  ± 1.582 
 
0.012 -0.102** 
Serum phosphate (mmol/L)  
  
1.129  ± 0.154  
  
1.117  ± 0.158 
  
0.067 0.161** 
 
Serum albumin (g/L)  44.2 ± 2.9  44.0 ± 3.1  0.084 0.426** 
Season (Winter and Spring)  2414  (44.2)  283  (44.8)  0.746 0.027* 
Continuous variables express as mean ± SD. 
Categorical variables express as n (%) 
^Adjusted for age and sex; **p-value < 0.01; *p-value < 0.05 
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Table 2. Association between serum calcium concentration and diabetes incidence. 
Variables 
 Crude model  Model 1  Model 2  Model 3 
 Hazard ratio per 
1-SD increment 
(95% CI) 
P-value 
 Hazard ratio per 
1-SD increment 
(95% CI) 
P-value  
Hazard ratio per 
1-SD increment 
(95% CI) 
P-value  
Hazard ratio per 
1-SD increment 
(95% CI) 
P-value 
Total 
calcium 
 
1.19 (1.10-1.28) <0.001 
 
1.16 (1.08-1.25) <0.001  1.16 (1.08-1.26) <0.001  1.11 (1.02-1.21) 0.016 
Albumin-
corrected 
calcium 
 
1.28 (1.18-1.38) <0.001 
 
1.09 (1.01-1.18) 0.026  1.08 (1.00-1.17) 0.066  1.10 (1.02-1.20) 0.018 
Model 1: adjusted for age and sex. 
Model 2: model 1 further adjusted for BMI, smoking status, drinking status, and physical activity. 
Model 3: model 2 further adjusted for serum albumin, serum phosphate, parathyroid hormone, alkaline phosphatase, femoral neck BMD 
T-score, and season.   
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Table 3. Hazard ratio (HR) of incident diabetes by quartiles of serum calcium concentration. 
Variables   Q1 Q2 Q3 Q4 PTrend 
Total 
calcium 
Cutoff 
(mmol/l) 
<2.33 2.33 to 2.38 2.39 to 2.44 >2.44 
 
Crude 1 1.18 (0.93-1.50) 1.42 (1.12-1.79) 1.53 (1.21-1.92) <0.001 
Model 1 1 1.21  (0.96-1.54) 1.45  (1.15-1.83) 1.49  (1.18-1.87) <0.001 
Model 2 1 1.22  (0.96-1.55) 1.47 (1.16-1.85) 1.49 (1.18-1.87) <0.001 
Model 3 1 1.17  (0.91-1.49) 1.37 (1.07-1.74) 1.32 (1.02-1.70) 0.032 
Albumin-
corrected 
calcium 
Cutoff 
(mmol/l) 
<2.25 2.25 to 2.29 2.30 to 2.35 >2.35  
Crude 1 1.04  (0.81-1.35) 1.32  (1.05-1.67) 1.86  (1.48-2.34) <0.001 
Model 1 1 0.91  (0.71-1.17) 1.05  (0.83-1.32) 1.22  (0.96-1.53) 0.028 
Model 2 1 0.93  (0.72-1.20) 1.01 (0.79-1.27) 1.17 (0.93-1.48) 0.082 
Model 3 1 0.96  (0.75-1.24) 1.04 (0.82-1.32) 1.22 (0.96-1.55) 0.046 
Data are presented as HR (95% CI) 
Model adjustments are the same as indicated in Table 2.  
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Figure 1. Forest plots in meta-analysis. 
a) Association between serum total calcium levels and diabetes risk. 
 
b) Association between albumin-corrected calcium levels and diabetes risk. 
 
 
 
